"Chengdu Easton Bio Pharmaceuticals Co., Ltd."Announcement on Voluntary Disclosure of the Initiation of Phase I/II Clinical Trial for HP-002 Tablets and Completion of First Subject Enrollment and Dosing

Announcement on Voluntary Disclosure of the Initiation of Phase I/II Clinical Trial for HP-002 Tablets and Completion of First Subject Enrollment and Dosing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment